FlexiCath
Tel Aviv
About FlexiCath
Flexicath develops and markets sterile catheter insertion systems that solve the most problematic and expensive issues of Midterm (up to 29 days Indwelling) IV catheterization. Flexicath is a pioneer and in the Midterm category, coupling proprietary new innovations and proven industry technology to deliver the world’s best and safest midterm catheter. Their M/29 Midterm Catheter System was designed to answer an obvious need for a safe, easy-to-insert catheter for intermediate dwell applications. It is the only touch-free midline that can be placed in under 10 minutes following minimal training.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $754.0K
- Last round: Series Unknown (Jan 2007)
- Website: flexicath.com
- Phone: 97248500684
Industries & Categories
Manufacturing, Marketing, Medical
Canonical: https://fsome.com/organization/flexicath-2123574 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.